Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal AntibodiesMaria Silvia Cona, Massimo Di Nicola, Michele Del Vecchio et al.|Cancers|2019Cited by 30
Hyperprogression during immuno-checkpoint inhibitors (ICIs): A clinically significant problem?Elena Farè, Filippo de Braud, Silvana Sdao et al.|Annals of Oncology|2018Cited by 2